X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA CADILA HEALTHCARE ELDER PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x -0.2 23.0 - View Chart
P/BV x 0.1 5.1 2.0% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ELDER PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
CADILA HEALTHCARE
Mar-17
ELDER PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs380460 82.6%   
Low Rs188305 61.6%   
Sales per share (Unadj.) Rs491.292.1 533.3%  
Earnings per share (Unadj.) Rs-3.214.8 -21.5%  
Cash flow per share (Unadj.) Rs14.418.5 78.0%  
Dividends per share (Unadj.) Rs03.20 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.568.0 553.8%  
Shares outstanding (eoy) m20.541,023.74 2.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.64.2 13.9%   
Avg P/E ratio x-89.325.8 -345.8%  
P/CF ratio (eoy) x19.720.7 95.2%  
Price / Book Value ratio x0.85.6 13.4%  
Dividend payout %021.6 0.0%   
Avg Mkt Cap Rs m5,833391,581 1.5%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2,17915,002 14.5%   
Avg. sales/employee Rs ThNM5,594.5-  
Avg. wages/employee Rs ThNM890.1-  
Avg. net profit/employee Rs ThNM899.9-  
INCOME DATA
Net Sales Rs m10,08994,295 10.7%  
Other income Rs m2571,286 20.0%   
Total revenues Rs m10,34695,581 10.8%   
Gross profit Rs m-79219,036 -4.2%  
Depreciation Rs m3613,750 9.6%   
Interest Rs m2,756450 612.5%   
Profit before tax Rs m-3,65316,122 -22.7%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713-3 -123,756.7%   
Tax Rs m1251,289 9.7%   
Profit after tax Rs m-6515,168 -0.4%  
Gross profit margin %-7.820.2 -38.9%  
Effective tax rate %-3.48.0 -42.9%   
Net profit margin %-0.616.1 -4.0%  
BALANCE SHEET DATA
Current assets Rs m9,24060,223 15.3%   
Current liabilities Rs m9,99853,058 18.8%   
Net working cap to sales %-7.57.6 -98.8%  
Current ratio x0.91.1 81.4%  
Inventory Days Days4670 66.3%  
Debtors Days Days6088 68.0%  
Net fixed assets Rs m10,12472,984 13.9%   
Share capital Rs m2061,024 20.1%   
"Free" reserves Rs m5,58268,576 8.1%   
Net worth Rs m7,73469,600 11.1%   
Long term debt Rs m4,88924,684 19.8%   
Total assets Rs m22,882152,207 15.0%  
Interest coverage x-0.336.8 -0.9%   
Debt to equity ratio x0.60.4 178.3%  
Sales to assets ratio x0.40.6 71.2%   
Return on assets %11.810.3 114.6%  
Return on equity %-0.821.8 -3.9%  
Return on capital %22.317.9 124.4%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30721,280 1.4%   
Fx outflow Rs m12510,874 1.2%   
Net fx Rs m18110,406 1.7%   
CASH FLOW
From Operations Rs m11,75413,495 87.1%  
From Investments Rs m-561-29,103 1.9%  
From Financial Activity Rs m-6,76223,158 -29.2%  
Net Cashflow Rs m4,4327,556 58.7%  

Share Holding

Indian Promoters % 39.6 74.8 52.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 8.3 90.4%  
FIIs % 16.8 5.9 284.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 11.0 328.2%  
Shareholders   16,479 44,069 37.4%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  CIPLA  ABBOTT INDIA  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; SBI Up 3.7%(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS